Health
Looking beyond COVID-19’s spike protein for the next wave of vaccines – FierceBiotech
Most ongoing vaccine development efforts against the novel coronavirus focus on the spike protein on the surface of SARS-CoV-2. But a team led by immuno-oncology specialist TScan Therapeutics found that memory CD8+ T cells from recovered patients mainly targe…
Most ongoing vaccine development efforts against the novel coronavirus use the spike protein on the surface of SARS-CoV-2 in the hopes of inducing neutralizing antibodies that can directly block the virus from infecting healthy cells. But there could be one major caveat to that approach: The antibody response to the virus, mediated by B cells of the immune system, appears to wane quickly.
Thats why a research team led by immuno-oncology biotech TScan Therapeutics turned to another key component…
-
Noosa News14 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News12 hours agoQueensland Drug and Alcohol Court provides sentencing options – Proctor
-
Business14 hours agoSolid superannuation gains continue to roll in
-
General12 hours agoSingapore’s world-first sustainable flights tax will see some Australians pay more to travel